(Nicolas Economou/Getty Images)

Frontier takes off in the wake of Spirit’s second bankruptcy filing

Deutsche Bank said Frontier is the big winner of Spirit’s collapse, sending its shares up and those of its rivals downward.

Max Knoblauch

9/2/25 9:22AM

The skies are looking a bit more blue today for Frontier Airlines.

The low-cost carrier stands to benefit the most from Friday’s fresh bankruptcy filing by its budget rival Spirit Airlines, according to a recent note from Deutsche Bank. Deutsche Bank upgraded Frontier’s rating to “buy” from “hold” following the news, with analyst Michael Linenberg noting that more than a third of Frontier’s network overlaps with Spirit’s in the current quarter.

Frontier shares were up as much as 20% in Tuesday morning trading. Shares of budget flying rival JetBlue were up 2% in recent trading.

The whole ordeal is a cheaper way for Frontier to achieve its long-standing mission of eliminating competition from Spirit. Frontier has unsuccessfully tried to acquire the carrier twice since 2022 — a failed merger that would have created the US’s fifth-largest airline. Now, Frontier will have even more opportunity to eat Spirit’s market share, without the need to get approval from antitrust regulators.

Last week, Frontier said it would launch 20 new routes this winter. Many of those will be in Spirit’s major markets.

Luke Kawa

9/5/25

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Shares of Robinhood Markets, AppLovin, and Emcor are all rallying in post-market trading on Friday upon news that they’re being added to the S&P 500.

Shares of the brokerage popped 7.2%, the adtech company rose 7.8%, and the construction company was up a more modest 2.7% in the minutes following the announcement.

(Robinhood Markets, Inc. is the parent company of Sherwood Media, an independently operated media company subject to certain legal and regulatory restrictions.)

Strategy, another stock rumored to be in the running for inclusion in the benchmark US stock index that has been passed over, sank 2.5% in postmarket trading.

Nia Warfield, Luke Kawa

9/5/25

S&P 500 falls as rate-cut optimism fizzles

The S&P 500 gave up early gains to close down 0.3%, while the Nasdaq 100 eked out a 0.1% advance and the Russell 2000 outperformed, rising 0.5%.

Nia Warfield

9/5/25

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

Kenvue sank 15% Friday after a WSJ report said Health and Human Services Secretary Robert F. Kennedy Jr. may attempt to link prenatal Tylenol use to autism in an upcoming government report.

Kenvue, the maker of Tylenol and formerly a division of Johnson & Johnson prior to a 2023 spin-out, pushed back, saying the science shows “no causal link” between acetaminophen use during pregnancy and autism, and pointed to FDA and medical groups that agree on the drug’s safety.

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

RFK Jr., HHS to Link Autism to Tylenol Use in Pregnancy and Folate Deficiencies

The FDA itself has found no “clear evidence” of harm but advises pregnant women to consult providers before taking OTC meds.

The report is also expected to float a folate-derived therapy as a potential treatment.

Tylenol is just the latest well-established medication to face scrutiny under Kennedy, who has already stirred controversy by reshaping vaccine policy and amplifying doubts about mRNA shots.

Kenvue shares are now down over 18% year-to-date.

Max Knoblauch

9/5/25

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

It’s been a shortened week, but still a rough one for Lucid. Investor blowback to the luxury EV maker’s 1-for-10 reverse stock split has sent shares to all time lows this week.

After six straight days of closing lower, Wall Street appears to have decided enough is enough and is loading up on Lucid shares on Friday, sending them up 13% in recent trading. As of 2:10pm eastern, Lucid trading volumes were at more than 240% of their 30 day average.

Some of the move could be attributed to traders reading headlines that don’t take into consideration Lucid’s reverse split. Cantor Fitzgerald on Friday slapped a new price target on Lucid of $20, compared to its previous target of $3. Some news outlets (not us!) presented that as an increase. The problem: With the 1-for-10 reverse split in effect, a comparable price target would have been $30. The new $20 target is actually... a cut.

Matt Phillips

9/5/25

Palantir slips under 50-day moving average, amid momo reversal

What goes up, doesn’t always keep going up.

Palantir CEO Alex Karp PLTR insane valuation

Frontier takes off in the wake of Spirit’s second bankruptcy filing

More Markets

Robinhood, AppLovin, and Emcor pop on announcement of addition to S&P 500

Kenvue plunges after reports suggest RFK Jr. may try to link prenatal Tylenol use to autism

RFK Jr., HHS to Link Autism to Tylenol Use in Pregnancy and Folate Deficiencies

Lucid surges following 6 days of losses after headlines misidentify Cantor Fitzgerald’s lower split-adjusted price target as a good thing

Latest Stories